Catherine Mathis

Catherine joined Coave in September 2022 and brings over 30 years of experience in development and regulatory affairs in the pharmaceutical and biotech industries. Catherine spent 20 years at Transgene as Senior Director, Head of Regulatory Affairs setting up and leading the regulatory affairs department and supervising global regulatory activities for the development of gene therapy products in genetic diseases and immuno-oncology. Catherine has also held senior leadership and regulatory roles at Voisin Consulting Life Sciences, TxCell (a subsidiary of Sangamo Therapeutics), Elsalys Biotech, and most recently Enterome for the development of cell therapy products, monoclonal antibodies, and peptide-based vaccines, respectively, in oncology and GI diseases fields.

Catherine holds a PharmD and a Master’s degree in applied and basic toxicology from Paris University. She began her career in clinical research roles at Ipsen and Sanofi Pasteur.